1. Home
  2. SLNO vs SLGN Comparison

SLNO vs SLGN Comparison

Compare SLNO & SLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • SLGN
  • Stock Information
  • Founded
  • SLNO 1999
  • SLGN 1987
  • Country
  • SLNO United States
  • SLGN United States
  • Employees
  • SLNO N/A
  • SLGN N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SLGN Containers/Packaging
  • Sector
  • SLNO Health Care
  • SLGN Industrials
  • Exchange
  • SLNO Nasdaq
  • SLGN Nasdaq
  • Market Cap
  • SLNO 3.8B
  • SLGN 4.5B
  • IPO Year
  • SLNO 2014
  • SLGN 1997
  • Fundamental
  • Price
  • SLNO $62.37
  • SLGN $42.80
  • Analyst Decision
  • SLNO Strong Buy
  • SLGN Strong Buy
  • Analyst Count
  • SLNO 9
  • SLGN 9
  • Target Price
  • SLNO $116.78
  • SLGN $62.22
  • AVG Volume (30 Days)
  • SLNO 2.7M
  • SLGN 1.2M
  • Earning Date
  • SLNO 11-05-2025
  • SLGN 10-29-2025
  • Dividend Yield
  • SLNO N/A
  • SLGN 1.86%
  • EPS Growth
  • SLNO N/A
  • SLGN N/A
  • EPS
  • SLNO N/A
  • SLGN 2.81
  • Revenue
  • SLNO $32,656,999.00
  • SLGN $6,162,113,000.00
  • Revenue This Year
  • SLNO N/A
  • SLGN $11.86
  • Revenue Next Year
  • SLNO $181.85
  • SLGN $2.75
  • P/E Ratio
  • SLNO N/A
  • SLGN $15.31
  • Revenue Growth
  • SLNO N/A
  • SLGN 5.49
  • 52 Week Low
  • SLNO $41.50
  • SLGN $41.30
  • 52 Week High
  • SLNO $90.32
  • SLGN $58.14
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 48.83
  • SLGN 38.81
  • Support Level
  • SLNO $55.78
  • SLGN $42.07
  • Resistance Level
  • SLNO $68.46
  • SLGN $43.16
  • Average True Range (ATR)
  • SLNO 4.12
  • SLGN 0.70
  • MACD
  • SLNO 0.71
  • SLGN 0.22
  • Stochastic Oscillator
  • SLNO 67.58
  • SLGN 67.54

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About SLGN Silgan Holdings Inc.

Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.

Share on Social Networks: